NASDAQ:ALDR Alder Biopharmaceuticals (ALDR) Stock Price, News & Analysis → The attacks will come for me after releasing this… (From Porter & Company) (Ad) Free ALDR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$18.88▼$18.8850-Day Range$18.88▼$18.8852-Week Range$8.39▼$19.12VolumeN/AAverage Volume5.12 million shsMarket Capitalization$1.58 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Alder Biopharmaceuticals alerts: Email Address Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. About Alder Biopharmaceuticals Stock (NASDAQ:ALDR)Alder BioPharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It discovers, develops, and commercializes therapeutic antibodies to transform the treatment paradigm for patients with migraine in the United States, Australia, and Ireland. The company's lead product candidate is eptinezumab, a monoclonal antibody (mAb) inhibiting calcitonin gene-related peptide, which is in the late-stage clinical development for the prevention of migraine. It also develops ALD1910, a preclinical mAb that inhibits pituitary adenylate cyclase-activating polypeptide-38 for migraine prevention; and Clazakizumab, a mAb inhibiting the pro-inflammatory cytokine interleukin-6 that has completed two Phase 2b clinical trials. The company has strategic collaboration with CSL Limited for the development of clazakizumab as a therapeutic option for solid organ transplant rejection. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.Read More Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. ALDR Stock News HeadlinesMay 28, 2024 | msn.comCommunity stalwart Angela Alder granted Freedom of the Town of SawbridgeworthMay 24, 2024 | msn.comOHSAA track & field: Jonathan Alder, Licking Valley boys win Division II regional titlesMay 23, 2024 | msn.comGreg Kennedy's perfect game for Jonathan Alder highlights OHSAA baseball district finalsMay 21, 2024 | msn.comYoung girl's cancer battle inspires Phil to shave bushy beard off for Alder HeyMay 17, 2024 | msn.comTop-ranked Jonathan Alder ends Licking Valley's championship baseball seasonMay 9, 2024 | msn.comAlder Hey delays community park return plan againMay 8, 2024 | benzinga.comJames J Bochnowski's Net WorthMay 6, 2024 | msn.comDad turned away from Alder Hey car park as he had electric vehicleApril 24, 2024 | msn.comAlder Hey unveils plans to take on former police stationApril 23, 2024 | msn.comControversial housing plans on old Alder Hey site get green lightApril 18, 2024 | msn.comRomesh Ranganathan makes wonderful gesture during surprise Alder Hey visitApril 16, 2024 | msn.comRomesh Ranganathan in surprise visit to Alder HeyApril 15, 2024 | msn.comRomesh Ranganathan's incredible gesture after Alder Hey visitApril 12, 2024 | msn.comFormer Alder Hey doctor who emptied mum's bin on driveway is bannedApril 12, 2024 | msn.comGrand National winners greet children at Alder Hey as 35th runner namedApril 11, 2024 | msn.comMore than four in five A&E arrivals at Alder Hey Children's Hospital seen within four hours – meeting Government's recovery targetApril 11, 2024 | msn.comFormer Alder Hey doctor turned up at mum's home and emptied bin onto drivewayApril 2, 2024 | msn.comTraffic lights out after car crash in Alder Road, PooleMarch 21, 2024 | msn.comObama Drive? Alder proposes renaming prominent Chicago street for former presidentMarch 18, 2024 | msn.comTributes paid to lifelong Swindon Town supporter Ann AlderMarch 14, 2024 | msn.comRishi Sunak's NHS pledge one year on: Waiting lists up at Alder Hey Children's HospitalMarch 12, 2024 | msn.comMore women than men working as doctors at Alder Hey Children's Hospital – bucking trend across NHSMarch 9, 2024 | msn.comHartley, Jonathan Alder win OHSAA Division II boys basketball district championshipsFebruary 19, 2024 | msn.comSchoolboy flown to Alder Hey in serious condition after mountain fallFebruary 9, 2024 | msn.comAlder Hey Children's Trust cares for eight patients with Covid-19 in hospitalSee More Headlines Receive ALDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alder Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2018Today6/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:ALDR CUSIPN/A CIK1423824 Webwww.alderbio.com Phone425-205-2900FaxN/AEmployees202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-296,430,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-226.13% Return on Assets-66.86% Debt Debt-to-Equity Ratio1.74 Current Ratio8.94 Quick Ratio8.94 Sales & Book Value Annual Sales$1.62 million Price / Sales977.10 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book11.73Miscellaneous Outstanding Shares83,840,000Free FloatN/AMarket Cap$1.58 billion OptionableOptionable Beta2.64 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesDr. John A. Latham (Age 59)Co-Founder & Chief Scientific Officer Mr. Larry K. Benedict (Age 58)Principal Accounting Officer & Exec. VP Dr. Jeffrey T. L. Smith (Age 59)Managing Director of Alder Biopharmaceuticals Limited Mr. Robert W. Azelby (Age 51)Pres, CEO & Director Mr. Carlos CampoyChief Financial OfficerKey CompetitorsMadrigal PharmaceuticalsNASDAQ:MDGLViking TherapeuticsNASDAQ:VKTXIonis PharmaceuticalsNASDAQ:IONSCytokineticsNASDAQ:CYTKSummit TherapeuticsNASDAQ:SMMTView All Competitors ALDR Stock Analysis - Frequently Asked Questions How were Alder Biopharmaceuticals' earnings last quarter? Alder Biopharmaceuticals Inc (NASDAQ:ALDR) posted its earnings results on Tuesday, August, 7th. The biopharmaceutical company reported ($1.04) earnings per share for the quarter, topping the consensus estimate of ($1.05) by $0.01. What other stocks do shareholders of Alder Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alder Biopharmaceuticals investors own include NVIDIA (NVDA), AbbVie (ABBV), (CPXX) (CPXX), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), Synergy Pharmaceuticals (SGYP), Sarepta Therapeutics (SRPT) and Celldex Therapeutics (CLDX). This page (NASDAQ:ALDR) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alder Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alder Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.